Some patients with Hepatitis C are to be given early access to powerful new drugs, the Minister for Health has announced.
He said that the HSE is putting in place a programme to provide early
access to new ‘direct-acting, antiviral drugs for hepatitis C patients
with the greatest clinical need, due to the advanced nature of their
Around 120 patients are set to benefit from the move.
(Editorial comment: It is estimated that 20,000-50,000 people in Ireland are chronically infected with HCV, a population prevalence of 0·5-1·2%. http://www.ncbi.nlm.nih.gov/pubmed/21923968)
Labels: access to DAA's, Ireland